Skip Page Header

Home > Drug treatment matrix cell D1: organisational functioning - reducing harm.

Drug and Alcohol Findings. (2017) Drug treatment matrix cell D1: organisational functioning - reducing harm. Drug and Alcohol Findings Drug Treatment Matrix .

[img]
Preview
PDF (Drug Matrix cell D1)
842kB

URL: http://findings.org.uk/PHP/dl.php?file=Matrix/Drug...


The Drug Matrix is concerned with the treatment of problems related to the use of illegal drugs by adults (another deals with alcohol-related problems). It maps the treatment universe and for each sub-territory (a cell) lists the most important UK-relevant research and guidance. Across the top columns move from specific interventions through how their impacts are affected by staff, the management of the service, and the nature of the organisation, to the impact of local area treatment systems. Down the rows are the major intervention types implemented at these levels.

What is cell D1 about?

Described more fully in cell A1’s bite, this entire row is about reducing the harms experienced by the user as a result of their drug use, without necessarily reducing use or seeking to overcome dependence. Common interventions include needle exchanges, overdose prevention programmes, and substituting a legally prescribed drug of the same type for the original (and usually illegally obtained) substance, also considered as a treatment for addiction in row 3 of the matrix.

This cell is, however, not about the content of the intervention (for which see cell A1), but about what kinds of organisations are best placed to deliver these. Organisational ethos and objectives largely determine operational policies such as methadone dosing and how many needles and syringes injectors are given by exchanges and on what terms. In turn these directly affect the service’s potential to reduce harm.

Repository Staff Only: item control page